Research Papers

25 of 170 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Severe COVID-19 <i>versus</i> multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infectio…
Fraser R; Orta-Resendiz A; Dockrell D; Müller-Trutwin M; Mazein A.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Patient-reported outcome measures for paediatric acute lower respiratory infection studies.
Oakes DB; Baker MJ; McLeod C; Nattabi B; Blyth CC.
Eur Respir Rev (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Forbearance with endobronchial stenting: cognisance before conviction.
Avasarala SK; Dutau H; Mehta AC.
Eur Respir Rev (Unknown)
Published: 2023
2/6 Transparent
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.
Kolb M; Crestani B; Maher TM.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021.
Simonneau G; Fadel E; Vonk Noordegraaf A; Toshner M; Lang IM; Klok FA; McInnis MC; Screaton N; Madani MM; Martinez G; Salaunkey K; Jenkins DP; Matsubara H; Brénot P; Hoeper MM; Ghofrani HA; Jaïs X; Wiedenroth CB; Guth S; Kim NH; Pepke-Zaba J; Delcroix M; Mayer E.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD.
Calderon AA; Dimond C; Choy DF; Pappu R; Grimbaldeston MA; Mohan D; Chung KF.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The role of confocal laser endomicroscopy in pulmonary medicine.
Tian S; Huang H; Zhang Y; Shi H; Dong Y; Zhang W; Bai C.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Physical activity promotion interventions in chronic airways disease: a systematic review and meta-analysis.
Reilly C; Sails J; Stavropoulos-Kalinoglou A; Birch RJ; McKenna J; Clifton IJ; Peckham D; Birch KM; Price OJ.
Eur Respir Rev (Unknown)
Published: 2023
3/6 Transparent
Registered
New antibiotics for Gram-negative pneumonia.
Bassetti M; Magnè F; Giacobbe DR; Bini L; Vena A.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Circulating tumour cells in patients with lung cancer universally indicate poor prognosis.
Jin F; Zhu L; Shao J; Yakoub M; Schmitt L; Reißfelder C; Loges S; Benner A; Schölch S.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Pulmonary aspergillosis: diagnosis and treatment.
Lamoth F; Calandra T.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of…
Nguyen-Van-Tam JS; O'Leary M; Martin ET; Heijnen E; Callendret B; Fleischhackl R; Comeaux C; Tran TMP; Weber K.
Eur Respir Rev (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of …
Zinellu A; Zinellu E; Mangoni AA; Pau MC; Carru C; Pirina P; Fois AG.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and met…
Lee B; Lewis G; Agyei-Manu E; Atkins N; Bhattacharyya U; Dozier M; Rostron J; Sheikh A; McQuillan R; Theodoratou E; Usher Network for COVID-19 Evidence Reviews (UNCOVER) group.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
How and when to manage respiratory infections out of hospital.
Cavallazzi R; Ramirez JA.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Non-<i>Aspergillus</i> mould lung infections.
Puerta-Alcalde P; Garcia-Vidal C.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a…
Rodrigues I; Estêvão Gomes R; Coutinho LM; Rego MT; Machado F; Morais A; Novais Bastos H.
Eur Respir Rev (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolis…
Prosperi-Porta G; Ronksley P; Kiamanesh O; Solverson K; Motazedian P; Weatherald J.
Eur Respir Rev (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
The effects of COVID-19 on respiratory muscle performance: making the case for respiratory muscle testing and training.
Severin R; Franz CK; Farr E; Meirelles C; Arena R; Phillips SA; Bond S; Ferraro F; Faghy M; HL-PIVOT Network.
Eur Respir Rev (Unknown)
Published: 2022
2/6 Transparent
Ventilatory neural drive in chronically hypercapnic patients with COPD: effects of sleep and nocturnal noninvasive vent…
McCartney A; Phillips D; James M; Chan O; Neder JA; de-Torres JP; Domnik NJ; Crinion SJ.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Non-typeable <i>Haemophilus influenzae</i> airways infection: the next treatable trait in asthma?
Brown MA; Jabeen M; Bharj G; Hinks TSC.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
The 6-min walk test as a primary end-point in interstitial lung disease.
Harari S; Wells AU; Wuyts WA; Nathan SD; Kirchgaessler KU; Bengus M; Behr J.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Intensive <i>versus</i> short face-to-face smoking cessation interventions: a meta-analysis.
Rasmussen M; Lauridsen SV; Pedersen B; Backer V; Tønnesen H.
Eur Respir Rev (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Does pulmonary rehabilitation address treatable traits? A systematic review.
Holland AE; Wageck B; Hoffman M; Lee AL; Jones AW.
Eur Respir Rev (Unknown)
Published: 2022
2/6 Transparent
Air pollution as an early determinant of COPD.
Lu Z; Coll P; Maitre B; Epaud R; Lanone S.
Eur Respir Rev (Unknown)
Published: 2022
3/6 Transparent
Funding Declared